Carbone Cancer Center members take new leadership roles
Four members of the University of Wisconsin Carbone Cancer Center have been named to new leadership roles.
Personalized in vitro model enables drug screening for kidney cancer
One way to treat the most common type of kidney cancer is to use antiangiogenic drugs to cut off the blood supply to the tumors, but patients respond differently to the drugs, and choosing the wrong one can make the cancer grow faster.
The Ride funds $365,000 in research at Carbone Cancer Center
On a beautiful September Sunday, hundreds of bicyclists pedaled the roads of eastern Dane County on The Ride to raise money for cancer research.
First Carbone Cancer Center patient receives experimental therapy to prevent infections during chemotherapy
Michael Toelle, superintendent of the Tomorrow River Schools, recently became the first patient at the University of Wisconsin Carbone Cancer Center to be infused with an experimental cellular therapy designed to prevent infections in leukemia patients.
Wisconsin researchers well-represented at international radiation oncology conference
The 60th annual meeting of the American Society for Radiation Oncology (ASTRO), the world’s premier radiation oncology society, got underway this week in San Antonio, Texas, with a strong Wisconsin presence.
Breast cancer expert Kari Wisinski joins Big Ten research leadership
Kari Wisinski, MD, a breast cancer specialist with the University of Wisconsin Carbone Cancer Center, has been named to the steering committee of the Big Ten Cancer Research Consortium.
Mutations in key blood cell protein disrupt development, predispose to leukemia
When a key gene in blood cell development, GATA-2, is mutated, it causes a predisposition to the development of acute myeloid leukemia (AML), and the changes in GATA-2 were believed to diminish its protein function.
Sean Ronnekleiv-Kelly earns 2018 Carbone Young Investigator Award
Sean Ronnekleiv-Kelly, MD, a surgical oncologist with the UW Carbone Cancer Center and Department of Surgery, has been awarded the 2018 Paul P. Carbone Young Investigator Award to study causes of and treatments for pancreatic cancer. He joined UW Carbone in 2017.
Evie Carchman awarded $500,000 grant to study anal cancer
While people infected with HIV are living longer due to better therapies, their weakened immune systems are linked to what is now a leading cause of death in the HIV population: cancer.
Cell therapy is the future, and Wisconsin is the place, says Jacques Galipeau
Medicine is rapidly approaching a great advance that will augment or replace drugs with human cells for treating a range of intractable conditions, an expert in cell therapy told the Wisconsin Technology Council on June 26.
UW Carbone Cancer Center study to look for ways to personalize therapy in colorectal cancer
A five-year, $3 million grant from the National Cancer Institute will support UW Carbone Cancer Center physician-researcher Dusty Deming, MD, and colleagues in their pursuit of more effective treatments for colorectal-cancer patients.
Researchers discover effective way to generate powerful blood cells for immunotherapy
Scientists at the University of Wisconsin School of Medicine and Public Health have found a potentially improved method for creating T cells to treat cancer and infections.